This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Dec 20;32(36):4170.

doi: 10.1200/JCO.2014.57.9318. Epub 2014 Nov 10.

Neoadjuvant phase II studies of modified methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer

Bamidele A Adesunloye¹

Affiliations

PMID: 25385733
DOI: 10.1200/JCO.2014.57.9318

Comment

Neoadjuvant phase II studies of modified methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer

Bamidele A Adesunloye. J Clin Oncol. 2014.

. 2014 Dec 20;32(36):4170.

doi: 10.1200/JCO.2014.57.9318. Epub 2014 Nov 10.

Author

Bamidele A Adesunloye¹

Affiliation

¹ Indiana University School of Medicine, Lafayette, IN badesunloye@iuhealth.org.

PMID: 25385733
DOI: 10.1200/JCO.2014.57.9318

No abstract available

PubMed Disclaimer

Comment in

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye.
Sternberg CN, Apolo AB. Sternberg CN, et al. J Clin Oncol. 2014 Dec 20;32(36):4172-3. doi: 10.1200/JCO.2014.58.5299. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385726 No abstract available.
Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye.
Plimack ER, Hoffman-Censits J, Rosenberg JE, Wong YN, Bellmunt J, Choueiri TK. Plimack ER, et al. J Clin Oncol. 2014 Dec 20;32(36):4171-2. doi: 10.1200/JCO.2014.58.5281. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385730 No abstract available.

Comment on

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.
Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Plimack ER, et al. J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12. J Clin Oncol. 2014. PMID: 24821881 Free PMC article. Clinical Trial.
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.
Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, Krajewski KM, Kantoff PW, Ross RW, Rosenberg JE. Choueiri TK, et al. J Clin Oncol. 2014 Jun 20;32(18):1889-94. doi: 10.1200/JCO.2013.52.4785. Epub 2014 May 12. J Clin Oncol. 2014. PMID: 24821883 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information